Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 47 studies with search of: | "Immunotoxins" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma
|
||||
2 | Withdrawn |
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
||||
3 | Recruiting |
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
|
||||
4 | Suspended |
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
|
||||
5 | Recruiting |
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
|
||||
6 | Recruiting |
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
|
||||
7 | Completed |
Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia
|
||||
8 | Completed |
Immunotoxin in Treating Patients With Leukemia or Lymphoma
|
||||
9 | Completed |
LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors
|
||||
10 | Completed |
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
|
||||
11 | Completed |
Immunotoxin Therapy in Treating Patients With Advanced Cancer
|
||||
12 | Recruiting |
LMB-2 Immunotoxin in Treating Patients With Recurrent or Refractory Hairy Cell Leukemia
|
||||
13 | Recruiting |
LMB-2 Immunotoxin in Treating Patients With Cutaneous T-Cell Lymphoma
|
||||
14 | Recruiting |
LMB-2 Immunotoxin in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
|
||||
15 | Active, not recruiting |
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
|
||||
16 | Completed |
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma
|
||||
17 | Completed |
LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-Small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
|
||||
18 | Withdrawn |
Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
|
||||
19 | Terminated |
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
|
||||
20 | Recruiting |
Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |